Clinical Trials Directory

Trials / Unknown

UnknownNCT01505959

Blood Pressure Reduction Induced by CPAP in Sleep Apnea Patients at High Cardiovascular Risk : OPTISAS 2 Study

Blood Pressure Reduction Induced by Continuous Positive Airway Pressure (CPAP) in Sleep Apnea Patients at High Cardiovascular Risk : A Randomized Controlled Trial Comparing Usual CPAP Care Versus a Multidisciplinary and Coordinated Follow-up Based on a Telemonitoring Web Platform

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
936 (estimated)
Sponsor
Fédération Française de Pneumologie · Academic / Other
Sex
All
Age
18 Years – 78 Years
Healthy volunteers
Not accepted

Summary

Targeted population: Sleep apnea patients at high cardiovascular risk newly treated by CPAP Hypothesis: Improvement in blood pressure after 6 months of CPAP treatment might be greater in the telemonitoring arm compared to usual CPAP care. Main goal: To compare 6-months blood pressure reduction when Sleep Apnea patients at high cardiovascular risk are randomly allocated to usual CPAP care or a multidisciplinary and coordinated follow-up based on a telemonitoring web platform.

Detailed description

Study procedures: The telemonitoring system will involve respiratory physicians, home care providers and include regular assessments of home self-measured blood pressure, oximetry, physical activity recorded by actigraphy, CPAP compliance, side effects and residual events. Secured data transmission to medical staff computers and secured websites will allow easy telemonitoring. Automatic algorithms have been built-up for early adjustment of CPAP treatment in case of side effects, leaks and persistent residual events. An interim analysis will be performed when 300 patients will be included.

Conditions

Interventions

TypeNameDescription
DEVICECPAP treatmentUsual CPAP treatment
DEVICECPAP treatmentCPAP treatment with telemedicine system

Timeline

Start date
2013-02-01
Primary completion
2014-09-01
Completion
2014-12-01
First posted
2012-01-09
Last updated
2014-09-05

Locations

32 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01505959. Inclusion in this directory is not an endorsement.